Dermatology NewsOnline support tool improves AD self-managementNovember 2, 2022Atopic DermatitisPediatrics
Dermatology NewsAn integrative approach to atopic dermatitis features a long list of optionsOctober 31, 2022Atopic Dermatitis
Dermatology NewsRemote assessment of atopic dermatitis is feasible with patient-provided images: StudyOctober 26, 2022Atopic DermatitisPediatrics
Dermatology NewsDupilumab-associated ocular surface disease in patients with AD: Unraveling the linkOctober 25, 2022Atopic DermatitisPediatrics
Meta-analysis demonstrates long-term atopic dermatitis prevention with L. rhamnosus probioticOctober 24, 2022Atopic Dermatitis
Atopic dermatitis: Meta-analysis demonstrates efficacy of allergen immunotherapyOctober 24, 2022Atopic Dermatitis
Some immunomodulatory treatments increase risk for COVID-19 complications in atopic dermatitisOctober 24, 2022Atopic Dermatitis
Moderate-to-severe atopic dermatitis: Tralokinumab with or without TCS effective and safe in North American populationOctober 24, 2022Atopic Dermatitis
Altered skin biomarker levels predict atopic dermatitis risk in infantsOctober 24, 2022Atopic Dermatitis
Moderate-to-severe atopic dermatitis: Abrocitinib shows rapid itch reliefOctober 24, 2022Atopic Dermatitis
Atopic dermatitis: Rapid and sustained “itch-free” state with ruxolitinibOctober 24, 2022Atopic Dermatitis
Moderate-to-severe atopic dermatitis: Children younger than 6 years can now receive dupilumabOctober 24, 2022Atopic Dermatitis
